Keeler Thomas Management’s Gilead Sciences GILD Stock Holding History

Keeler Thomas Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,535	Closed	-$286K	–	73
2020 Q3	$286K	Sell	4,535 -1,615	-26%	-$112K	0.18%	62
2020 Q2	$473K	Sell	6,150 -500	-8%	-$38.3K	0.34%	54
2020 Q1	$497K	Buy	6,650 +1,700	+34%	+$117K	0.58%	45
2019 Q4	$321K	Sell	4,950 -300	-6%	-$19.5K	0.23%	58
2019 Q3	$332K	Buy	5,250 +150	+3%	+$9.8K	0.26%	55
2019 Q2	$344K	Buy	5,100 +100	+2%	+$6.58K	0.27%	50
2019 Q1	$325K	Buy	5,000 +600	+14%	+$39.9K	0.27%	50
2018 Q4	$275K	Sell	4,400 -5,300	-55%	-$370K	0.32%	50
2018 Q3	$748K	Hold	9,700	–	–	0.62%	39
2018 Q2	$687K	Sell	9,700 -600	-6%	-$42.4K	0.64%	36
2018 Q1	$776K	Hold	10,300	–	–	0.77%	34
2017 Q4	$737K	Buy	+10,300	New	+$782K	0.68%	35

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Keeler Thomas Management's GILD Position: Q4 2020 in Review

Keeler Thomas Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 4,535 shares — an estimated $286K sold.

Keeler Thomas Management first reported a position in GILD in Q4 2017 and held it in 12 quarters. The position peaked at $776K in Q1 2018. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Keeler Thomas Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
Keeler Thomas Management sold 4,535 Gilead Sciences shares in Q4 2020, an estimated $286K.
Keeler Thomas Management first reported a position in Gilead Sciences in Q4 2017 and held it in 12 quarters.
Keeler Thomas Management's Gilead Sciences position peaked at $776K in Q1 2018.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Keeler Thomas Management's 13F filing for Q4 2020, filed 26 Jan 2021.